deferoxamine has been researched along with methyltestosterone in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Vadász, G | 1 |
Crisafulli, A; Denuzzo, G; Frisina, N; Gaudio, A; Lasco, A; Meo, A; Morabito, N | 1 |
1 review(s) available for deferoxamine and methyltestosterone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for deferoxamine and methyltestosterone
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[A case of Diamond-Blackfan anemia: Experiences of 10-year follow-up study].
Topics: Adolescent; Anemia, Aplastic; Biopsy; Blood Transfusion; Child; Child, Preschool; Deferoxamine; Erythrocytes, Abnormal; Erythropoiesis; Folic Acid; Follow-Up Studies; Hemosiderosis; Hepatomegaly; Humans; Immunosuppressive Agents; Liver; Long-Term Care; Male; Methyltestosterone; Prednisolone; Prognosis; Remission, Spontaneous; Splenomegaly; Syndrome | 1974 |
Osteoporosis and beta-thalassemia major: role of the IGF-I/IGFBP-III axis.
Topics: Adult; beta-Thalassemia; Biomarkers; Bone and Bones; Bone Density; Cross-Sectional Studies; Deferoxamine; Estrogen Replacement Therapy; Female; Femur Neck; Hormone Replacement Therapy; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Iron Chelating Agents; Lumbar Vertebrae; Male; Medroxyprogesterone Acetate; Methyltestosterone; Osteoporosis; Reference Values | 2002 |